All the news Showing 10 of 33 articles from: CirrhosisGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Portal hypertension less likely to fall after HCV treatment when liver stiffness is severe Keith Alcorn / 24 November 2016 Curing hepatitis C infection moderately reduces portal hypertension, but has less impact in people with more severe liver stiffness due to fibrosis, Spanish researchers reported at the 2016 AASLD Liver Meeting last week ... When you eat may contribute to fatty liver disease as much as what you eat Liz Highleyman / 17 November 2016 People who skip breakfast and eat late at night may have an elevated risk of non-alcoholic fatty liver disease (NAFLD), according to research presented this week at the 2016 AASLD Liver Meeting in ... Even low levels of alcohol consumption increase the risk of liver cancer for people with HCV infection with compensated cirrhosis Michael Carter / 05 September 2016 Low-to-moderate alcohol consumption is associated with an increased risk of liver cancer for people with hepatitis C virus (HCV) infection with compensated cirrhosis, investigators from Belgium report in the Journal of Hepatology. Five-year incidence ... Diabetes is a risk factor for the development of liver cancer for people with cirrhosis successfully treated for HCV Michael Carter / 04 July 2016 Diabetes is a strong risk factor for hepatocellular carcinoma (HCC) in people with hepatitis C virus (HCV) infection who have received successful treatment for the infection, Swedish investigators report in Clinical Infectious Diseases. ... Emricasan may improve inflammation and liver function in people with cirrhosis Liz Highleyman / 13 May 2016 The novel caspase inhibitor emricasan led to improvements in various biomarkers and decreases in MELD scores in patients with liver cirrhosis due to hepatitis C, heavy alcohol use or other causes, with significant ... High cholesterol diet more harmful to the liver for women with hepatitis C than men Keith Alcorn / 17 February 2016 A diet high in cholesterol appears more harmful to the liver, and is more strongly linked to liver-related death and liver transplantation, in women with hepatitis C and advanced fibrosis but not ... Clinical impact of effective HCV DAAs: referrals for liver transplant drop after their introduction Keith Alcorn / 04 December 2015 The number of hepatitis C virus (HCV)-related referrals for liver transplant has declined significantly since the introduction of HCV direct-acting antivirals (DAAs), according to two US studies presented to the recent 2015 ... Liver fibrosis regression after hepatitis C treatment linked to reduced complications and death in people with HIV and HCV co-infection Liz Highleyman / 06 August 2015 People with HIV and HCV co-infection, with liver cirrhosis, who achieve sustained virological response (SVR) and experience an improvement in liver fibrosis are less likely to develop liver disease complications or die from ... Sofosbuvir/ledipasvir plus ribavirin shows high cure rate for hepatitis C patients with advanced liver disease Liz Highleyman / 24 April 2015 An oral regimen of sofosbuvir/ledipasvir (Harvoni) and ribavirin taken for 12 or 24 weeks produced sustained virological response rates of 85-88% for people with genotype 1 or 4 hepatitis C virus ... Merck HCV combination achieves 90% cure in advanced cirrhosis Keith Alcorn / 24 April 2015 A 12-week course of treatment with two direct-acting antivirals in development by Merck cured hepatitis C infection in 90% of people with very advanced cirrhosis and at imminent risk of liver failure, ... ← Prev1234Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive